2444-6483 2444-6483 S2444-64832019000200058 10.24875/end.m19000007 México México México México México México México México México México México México México México México México 00 06 2019 00 06 2019 31 2 58 76

1 2006 333 726 2 2011 343 3 2013 369 1077 4 2013 368 2113-24 5 2010 35 64-101 6 2012 141 2 Suppl 2 Suppl e326S-50S 7 2012 141 2 Suppl 2 Suppl e24S-43S 8 2016 48 4 4 385-402 9 1984 74 979-83 10 Grading tutorial [Internet] 11 2008 336 924-6 12 2015 386 281-91 13 2016 108 89-96 14 2013 13 B B 8-15 15 2009 119 480-6 16 2015 27 4 4 458-64 17 2017 29 3 3 314-21 18 2017 62 3 3 730-8 19 2015 25 449-62 20 2018 67 3 3 405-17 21 2018 10 1 1 75-8 22 2017 136 1183-92 23 2009 373 1849-60 24 2009 119 1634-42 25 2017 152 1014-22 26 Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation 1994 154 1449-57 27 2004 59 44-8 28 2012 44 114-21 29 2013 13 136 30 2015 13 724-30 31 2014 12 651-61 32 2016 83 3-16 33 2017 15 46-52 34 2012 46 1617-26 35 2014 30 56-63 36 2015 33 9 9 1213-8 37 2005 115 6 6 455-9 38 2015 113 943-51 39 2015 386 680-90 40 2015 373 511-20 41 2015 373 2413-24 42 2008 57 1322-29 43 2018 36 4 4 328-32 44 2004 36 543-50 45 2009 7 1177-82 46 2014 2 2 2 123-30 47 2013 19 48 48 9453-60 48 2007 102 8 8 1781-8 49 2012 36 226-30 50 2016 22 26 26 5927-35 51 2012 47 7 7 770-4 52 2001 53 6 6 620-7 53 2004 99 1455-60 54 2008 67 1076-81 55 2000 95 1717-24 56 2009 70 6 6 1060-7 57 2012 10 692-4 58 2013 15 625-51 59 2014 35 28 28 1888-96 60 1994 19 283-7 61 2011 43 506-11 62 2015 42 949-56 63 2011 43 445-58 64 2017 30 7-14 65 1995 1 40-4 66 2011 154 311-24 67 2003 20 7 7 377-84 68 1992 102 4 4 312-26S 69 2009 119 1034-48 70 2008 168 1 1 63-9 71 2008 6 15 72 2018 30 4 4 433-40 73 2007 61 212-7 74 2011 32 414 75 2014 37 3 3 380-91 76 2013 163 160-7 77 2009 361 1139-51 78 2015 132 167-73